Novel Farnesol and Geranylgeraniol Analogues: A Potential New Class of Anticancer Agents Directed against Protein Prenylation
- 31 August 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 42 (19) , 3800-3808
- https://doi.org/10.1021/jm9902786
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Evidence for a High Affinity, Saturable, Prenylation-dependent p21 Binding Site in Plasma MembranesPublished by Elsevier ,1998
- Novel Salvage Pathway Utilizing Farnesol and Geranylgeraniol for Protein IsoprenylationBiochemical and Biophysical Research Communications, 1997
- THE POTENTIAL OF FARNESYLTRANSFERASE INHIBITORS AS CANCER CHEMOTHERAPEUTICSAnnual Review of Pharmacology and Toxicology, 1997
- Differential Prenyl Pyrophosphate Binding to Mammalian Protein Geranylgeranyltransferase-I and Protein Farnesyltransferase and Its Consequence on the Specificity of Protein PrenylationPublished by Elsevier ,1997
- Inhibitors of farnesyl:protein transferase—A possible cancer chemotherapeuticBioorganic & Medicinal Chemistry, 1996
- Geranylgeranyl Diphosphate-Based Inhibitors of Post-Translational Geranylgeranylation of Cellular ProteinsJournal of Medicinal Chemistry, 1996
- Yeast protein farnesyltransferase: steady-state kinetic studies of substrate bindingBiochemistry, 1995
- Mechanism of Farnesol Cytotoxicity: Further Evidence for the Role of PKC-Dependent Signal Transduction in Farnesol-Induced Apoptotic Cell DeathBiochemical and Biophysical Research Communications, 1995
- Specific Labeling of Isoprenylated Proteins: Application to Study Inhibitors of the Post-translational Farnesylation and GeranylgeranylationBiochemical and Biophysical Research Communications, 1995
- Phosphorylation of isoprenoid alcoholsThe Journal of Organic Chemistry, 1986